We were the first lupus organization in the U.S. to support stromal cell research. In partnership with the National Institute of Allergy and Infectious Diseases, we committed nearly $4 million over ...
December 2024, immediately following the approval of the world's first mesenchymal stromal cells clinical trial, the U.S. FDA ...
Scientists have uncovered a hidden driver of ovarian cancer—high-risk mesenchymal stem cells lurking in the fallopian tubes.
Bone morphogenetic proteins (BMPs) directly affect the osteogenic differentiation of stem cells and are integral to bone ...
Hosted on MSN1mon
Disruption of a single amino acid in a cellular protein makes breast cancer cells behave like stem cellsThe tumors in these mice showed high expression of cancer stem cell markers CD56 and CD20 ... long non-coding RNA XIST to suppress epithelial-mesenchymal transition and stemness in breast cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback